Advertisement

Index by author

July 01, 1993; Volume 21,Issue 4

A

  1. Abeysinghe, R D

    1. Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;

  2. Abiteboul, M

    1. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;

  3. Adusumalli, V E

    1. Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;

  4. Ahluwalia, G

    1. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;

  5. Anders, M W

    1. Gas-uptake pharmacokinetics and biotransformation of 1,1-dichloro-1-fluoroethane (HCFC-141b).
      G D Loizou and M W Anders
      Drug Metabolism and Disposition July 1993, 21 (4) 634-639;

  6. Arison, B H

    1. Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;

B

  1. Baillie, T A

    1. Stereochemical studies on the beta-oxidation of valproic acid in isolated rat hepatocytes.
      M A Shirley, P Hu and T A Baillie
      Drug Metabolism and Disposition July 1993, 21 (4) 580-586;

  2. Baker, D C

    1. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;

  3. Balani, S K

    1. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;

  4. Benet, L Z

    1. Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A.
      T Prueksaritanont, M A Correia, A E Rettie, D C Swinney, P E Thomas and L Z Benet
      Drug Metabolism and Disposition July 1993, 21 (4) 730-737;

  5. Benincosa, L J

    1. Inhibition of sulfate transport in rat kidney membrane vesicle preparations by nonsteroidal antiinflammatory drugs.
      L J Benincosa and M E Morris
      Drug Metabolism and Disposition July 1993, 21 (4) 750-752;

  6. Blackburn, R K

    1. Application of an immobilized digestive enzyme assay to measure chemical and enzymatic hydrolysis of the cyclic peptide antibiotic lysobactin.
      R K Blackburn and R B Van Breemen
      Drug Metabolism and Disposition July 1993, 21 (4) 573-579;

  7. Brett, C M

    1. Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;

C

  1. Cai, Y

    1. Redox cycling and hepatotoxicity of diquat in aging male Fischer 344 rats.
      L E Rikans, Y Cai, S D Kosanke and P S Venkataraman
      Drug Metabolism and Disposition July 1993, 21 (4) 605-610;

  2. Cashman, J R

    1. Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;

  3. Chiba, K

    1. The kinetic characterization of S-mephenytoin 4-hydroxylase (P-450IICMP) activity in human liver samples obtained as surgical waste from Japanese patients.
      K Chiba, K Kobayashi, M Tani, K Manabe and T Ishizaki
      Drug Metabolism and Disposition July 1993, 21 (4) 747-749;

  4. Chisena, C

    1. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;

  5. Chiu, S H

    1. Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;

  6. Choi, Y M

    1. Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;

  7. Chow, F S

    1. Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance.
      W Piekoszewski, F S Chow and W J Jusko
      Drug Metabolism and Disposition July 1993, 21 (4) 690-698;

  8. Cook, C E

    1. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;

  9. Correia, M A

    1. Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A.
      T Prueksaritanont, M A Correia, A E Rettie, D C Swinney, P E Thomas and L Z Benet
      Drug Metabolism and Disposition July 1993, 21 (4) 730-737;

  10. Coulombe, R A

    1. Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine.
      R A Coulombe, J M Huie, R P Sharma and J W Huggins
      Drug Metabolism and Disposition July 1993, 21 (4) 555-559;

D

  1. Dain, J G

    1. Biotransformation of fluvastatin sodium in humans.
      J G Dain, E Fu, J Gorski, J Nicoletti and T J Scallen
      Drug Metabolism and Disposition July 1993, 21 (4) 567-572;

  2. Dilea, C

    1. Comparative kinetics of sematilide in four species.
      P H Hinderling, C Dilea, T Koziol and G Millington
      Drug Metabolism and Disposition July 1993, 21 (4) 662-669;

  3. Dogterom, P

    1. Development of a simple incubation system for metabolism studies with precision-cut liver slices.
      P Dogterom
      Drug Metabolism and Disposition July 1993, 21 (4) 699-704;
    2. A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs. Qualitative and quantitative sex differences.
      P Dogterom and J Rothuizen
      Drug Metabolism and Disposition July 1993, 21 (4) 705-709;

  4. Donahue, B S

    1. Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment.
      N L Ferguson, B S Donahue, K A Tenney and E T Morgan
      Drug Metabolism and Disposition July 1993, 21 (4) 745-746;

  5. Dubois, N

    1. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;

F

  1. Feil, V J

    1. Metabolism and disposition of ractopamine hydrochloride by turkey poults.
      D J Smith, V J Feil, J K Huwe and G D Paulson
      Drug Metabolism and Disposition July 1993, 21 (4) 624-633;

  2. Ferguson, N L

    1. Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment.
      N L Ferguson, B S Donahue, K A Tenney and E T Morgan
      Drug Metabolism and Disposition July 1993, 21 (4) 745-746;

  3. Fournel-Gigleux, S

    1. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;

  4. Fu, E

    1. Biotransformation of fluvastatin sodium in humans.
      J G Dain, E Fu, J Gorski, J Nicoletti and T J Scallen
      Drug Metabolism and Disposition July 1993, 21 (4) 567-572;

G

  1. Gachon, F

    1. Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;

  2. Gaillard, G

    1. Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;

  3. Gelboin, H V

    1. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
      C Mani, H V Gelboin, S S Park, R Pearce, A Parkinson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 645-656;

  4. Giacomini, K M

    1. Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;

  5. Godeneche, D

    1. Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;

  6. Goldman, M E

    1. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;

  7. Gomez, D Y

    1. Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;

  8. Gorski, J

    1. Biotransformation of fluvastatin sodium in humans.
      J G Dain, E Fu, J Gorski, J Nicoletti and T J Scallen
      Drug Metabolism and Disposition July 1993, 21 (4) 567-572;

H

  1. Hao, Z

    1. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;

  2. Hasegawa, T

    1. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
      M Nadai, T Hasegawa, K Kato, L Wang, T Nabeshima and N Kato
      Drug Metabolism and Disposition July 1993, 21 (4) 611-616;

  3. Hebbler, A K

    1. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;

  4. Hider, R C

    1. Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;

  5. Hill, J M

    1. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;

  6. Hinderling, P H

    1. Comparative kinetics of sematilide in four species.
      P H Hinderling, C Dilea, T Koziol and G Millington
      Drug Metabolism and Disposition July 1993, 21 (4) 662-669;

  7. Hodgson, E

    1. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
      C Mani, E Hodgson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 657-661;

  8. Hoyer, G A

    1. Biotransformation of the antidepressant DL-rolipram. I. Isolation and identification of metabolites from rat, monkey, and human urine.
      W Krause, G Kühne, U Jakobs and G A Hoyer
      Drug Metabolism and Disposition July 1993, 21 (4) 682-689;

  9. Hu, P

    1. Stereochemical studies on the beta-oxidation of valproic acid in isolated rat hepatocytes.
      M A Shirley, P Hu and T A Baillie
      Drug Metabolism and Disposition July 1993, 21 (4) 580-586;

  10. Huggins, J W

    1. Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine.
      R A Coulombe, J M Huie, R P Sharma and J W Huggins
      Drug Metabolism and Disposition July 1993, 21 (4) 555-559;

  11. Huie, J M

    1. Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine.
      R A Coulombe, J M Huie, R P Sharma and J W Huggins
      Drug Metabolism and Disposition July 1993, 21 (4) 555-559;

  12. Huwe, J K

    1. Metabolism and disposition of ractopamine hydrochloride by turkey poults.
      D J Smith, V J Feil, J K Huwe and G D Paulson
      Drug Metabolism and Disposition July 1993, 21 (4) 624-633;

I

  1. Ishizaki, T

    1. The kinetic characterization of S-mephenytoin 4-hydroxylase (P-450IICMP) activity in human liver samples obtained as surgical waste from Japanese patients.
      K Chiba, K Kobayashi, M Tani, K Manabe and T Ishizaki
      Drug Metabolism and Disposition July 1993, 21 (4) 747-749;

J

  1. Jakobs, U

    1. Biotransformation of the antidepressant DL-rolipram. I. Isolation and identification of metabolites from rat, monkey, and human urine.
      W Krause, G Kühne, U Jakobs and G A Hoyer
      Drug Metabolism and Disposition July 1993, 21 (4) 682-689;

  2. Jeffcoat, A R

    1. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;

  3. Johns, D G

    1. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;

  4. Jusko, W J

    1. Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance.
      W Piekoszewski, F S Chow and W J Jusko
      Drug Metabolism and Disposition July 1993, 21 (4) 690-698;

K

  1. Kato, K

    1. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
      M Nadai, T Hasegawa, K Kato, L Wang, T Nabeshima and N Kato
      Drug Metabolism and Disposition July 1993, 21 (4) 611-616;

  2. Kato, N

    1. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
      M Nadai, T Hasegawa, K Kato, L Wang, T Nabeshima and N Kato
      Drug Metabolism and Disposition July 1993, 21 (4) 611-616;

  3. Kauffman, L R

    1. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;

  4. Kelley, J A

    1. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;

  5. Kimura, T

    1. Pharmacokinetics of zenarestat, an aldose reductase inhibitor, in male and female diabetic rats.
      Y Tanaka, T Sawamoto, A Suzuki and T Kimura
      Drug Metabolism and Disposition July 1993, 21 (4) 677-681;

  6. Kobayashi, K

    1. The kinetic characterization of S-mephenytoin 4-hydroxylase (P-450IICMP) activity in human liver samples obtained as surgical waste from Japanese patients.
      K Chiba, K Kobayashi, M Tani, K Manabe and T Ishizaki
      Drug Metabolism and Disposition July 1993, 21 (4) 747-749;

  7. Kosanke, S D

    1. Redox cycling and hepatotoxicity of diquat in aging male Fischer 344 rats.
      L E Rikans, Y Cai, S D Kosanke and P S Venkataraman
      Drug Metabolism and Disposition July 1993, 21 (4) 605-610;

  8. Koziol, T

    1. Comparative kinetics of sematilide in four species.
      P H Hinderling, C Dilea, T Koziol and G Millington
      Drug Metabolism and Disposition July 1993, 21 (4) 662-669;

  9. Krause, W

    1. Biotransformation of the antidepressant DL-rolipram. I. Isolation and identification of metabolites from rat, monkey, and human urine.
      W Krause, G Kühne, U Jakobs and G A Hoyer
      Drug Metabolism and Disposition July 1993, 21 (4) 682-689;

  10. Kucharczyk, N

    1. Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;

  11. Kühne, G

    1. Biotransformation of the antidepressant DL-rolipram. I. Isolation and identification of metabolites from rat, monkey, and human urine.
      W Krause, G Kühne, U Jakobs and G A Hoyer
      Drug Metabolism and Disposition July 1993, 21 (4) 682-689;

  12. Kupfer, D

    1. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
      C Mani, H V Gelboin, S S Park, R Pearce, A Parkinson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 645-656;
    2. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
      C Mani, E Hodgson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 657-661;

L

  1. Labarre, P

    1. Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;

  2. Lapicque, F

    1. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;

  3. Lee, P

    1. Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;

  4. Loizou, G D

    1. Gas-uptake pharmacokinetics and biotransformation of 1,1-dichloro-1-fluoroethane (HCFC-141b).
      G D Loizou and M W Anders
      Drug Metabolism and Disposition July 1993, 21 (4) 634-639;

M

  1. Madelmont, J C

    1. Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;

  2. Magdalou, J

    1. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;

  3. Manabe, K

    1. The kinetic characterization of S-mephenytoin 4-hydroxylase (P-450IICMP) activity in human liver samples obtained as surgical waste from Japanese patients.
      K Chiba, K Kobayashi, M Tani, K Manabe and T Ishizaki
      Drug Metabolism and Disposition July 1993, 21 (4) 747-749;

  4. Mani, C

    1. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
      C Mani, H V Gelboin, S S Park, R Pearce, A Parkinson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 645-656;
    2. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
      C Mani, E Hodgson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 657-661;

  5. Mantlo, N B

    1. Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;

  6. Marshall, L

    1. Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;

  7. Maurice, M H

    1. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;

  8. Miller, R R

    1. Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;

  9. Millington, G

    1. Comparative kinetics of sematilide in four species.
      P H Hinderling, C Dilea, T Koziol and G Millington
      Drug Metabolism and Disposition July 1993, 21 (4) 662-669;

  10. Mohammed, N

    1. Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;

  11. Moreau, M F

    1. Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;

  12. Morgan, E T

    1. Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment.
      N L Ferguson, B S Donahue, K A Tenney and E T Morgan
      Drug Metabolism and Disposition July 1993, 21 (4) 745-746;

  13. Morris, M E

    1. Inhibition of sulfate transport in rat kidney membrane vesicle preparations by nonsteroidal antiinflammatory drugs.
      L J Benincosa and M E Morris
      Drug Metabolism and Disposition July 1993, 21 (4) 750-752;

  14. Musser, S M

    1. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;

N

  1. Nabeshima, T

    1. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
      M Nadai, T Hasegawa, K Kato, L Wang, T Nabeshima and N Kato
      Drug Metabolism and Disposition July 1993, 21 (4) 611-616;

  2. Nadai, M

    1. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
      M Nadai, T Hasegawa, K Kato, L Wang, T Nabeshima and N Kato
      Drug Metabolism and Disposition July 1993, 21 (4) 611-616;

  3. Netter, P

    1. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;

  4. Nicoletti, J

    1. Biotransformation of fluvastatin sodium in humans.
      J G Dain, E Fu, J Gorski, J Nicoletti and T J Scallen
      Drug Metabolism and Disposition July 1993, 21 (4) 567-572;

O

  1. O'Brien, J A

    1. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;

  2. Olah, T V

    1. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;

P

  1. Papon, J

    1. Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;

  2. Park, S B

    1. Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;

  3. Park, S S

    1. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
      C Mani, H V Gelboin, S S Park, R Pearce, A Parkinson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 645-656;

  4. Parkinson, A

    1. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
      C Mani, H V Gelboin, S S Park, R Pearce, A Parkinson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 645-656;

  5. Patetta, P K

    1. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;

  6. Paulson, G D

    1. Metabolism and disposition of ractopamine hydrochloride by turkey poults.
      D J Smith, V J Feil, J K Huwe and G D Paulson
      Drug Metabolism and Disposition July 1993, 21 (4) 624-633;

  7. Pearce, R

    1. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
      C Mani, H V Gelboin, S S Park, R Pearce, A Parkinson and D Kupfer
      Drug Metabolism and Disposition July 1993, 21 (4) 645-656;

  8. Perez-Reyes, M

    1. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;

  9. Perno, C F

    1. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;

  10. Piekoszewski, W

    1. Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance.
      W Piekoszewski, F S Chow and W J Jusko
      Drug Metabolism and Disposition July 1993, 21 (4) 690-698;

  11. Pitzenberger, S M

    1. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;

  12. Porter, J B

    1. Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;

  13. Pritchard, M

    1. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;

  14. Prueksaritanont, T

    1. Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A.
      T Prueksaritanont, M A Correia, A E Rettie, D C Swinney, P E Thomas and L Z Benet
      Drug Metabolism and Disposition July 1993, 21 (4) 730-737;

  15. Pugh, D E

    1. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;

R

  1. Ramjit, H G

    1. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;

  2. Rettie, A E

    1. Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A.
      T Prueksaritanont, M A Correia, A E Rettie, D C Swinney, P E Thomas and L Z Benet
      Drug Metabolism and Disposition July 1993, 21 (4) 730-737;

  3. Rikans, L E

    1. Redox cycling and hepatotoxicity of diquat in aging male Fischer 344 rats.
      L E Rikans, Y Cai, S D Kosanke and P S Venkataraman
      Drug Metabolism and Disposition July 1993, 21 (4) 605-610;

  4. Romanyshyn, L A

    1. Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;

  5. Rosegay, A

    1. Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;

  6. Rothuizen, J

    1. A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs. Qualitative and quantitative sex differences.
      P Dogterom and J Rothuizen
      Drug Metabolism and Disposition July 1993, 21 (4) 705-709;

S

  1. Sadler, B M

    1. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;

  2. Sawamoto, T

    1. Pharmacokinetics of zenarestat, an aldose reductase inhibitor, in male and female diabetic rats.
      Y Tanaka, T Sawamoto, A Suzuki and T Kimura
      Drug Metabolism and Disposition July 1993, 21 (4) 677-681;

  3. Scallen, T J

    1. Biotransformation of fluvastatin sodium in humans.
      J G Dain, E Fu, J Gorski, J Nicoletti and T J Scallen
      Drug Metabolism and Disposition July 1993, 21 (4) 567-572;

  4. Schorn, T W

    1. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;

  5. Sharma, R P

    1. Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine.
      R A Coulombe, J M Huie, R P Sharma and J W Huggins
      Drug Metabolism and Disposition July 1993, 21 (4) 555-559;

  6. Shirley, M A

    1. Stereochemical studies on the beta-oxidation of valproic acid in isolated rat hepatocytes.
      M A Shirley, P Hu and T A Baillie
      Drug Metabolism and Disposition July 1993, 21 (4) 580-586;

  7. Siest, G

    1. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
      N Dubois, F Lapicque, M H Maurice, M Pritchard, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Drug Metabolism and Disposition July 1993, 21 (4) 617-623;

  8. Singh, S

    1. Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
      P Lee, N Mohammed, L Marshall, R D Abeysinghe, R C Hider, J B Porter and S Singh
      Drug Metabolism and Disposition July 1993, 21 (4) 640-644;

  9. Smith, D J

    1. Metabolism and disposition of ractopamine hydrochloride by turkey poults.
      D J Smith, V J Feil, J K Huwe and G D Paulson
      Drug Metabolism and Disposition July 1993, 21 (4) 624-633;

  10. Smith, J L

    1. Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;

  11. Smith, S J

    1. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;

  12. Sofia, R D

    1. Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;

  13. Soria, I

    1. Disposition of (-)carbovir in the in situ perfused rat liver and intestinal vasculature preparations.
      I Soria and C L Zimmerman
      Drug Metabolism and Disposition July 1993, 21 (4) 724-729;

  14. Sparadoski, R E

    1. Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;

  15. Stearns, R A

    1. Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
      R A Stearns, R R Miller, B H Arison, A Rosegay, J L Smith, N B Mantlo and S H Chiu
      Drug Metabolism and Disposition July 1993, 21 (4) 670-676;

  16. Stowe, E E

    1. Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.
      Z Hao, E E Stowe, G Ahluwalia, D C Baker, A K Hebbler, C Chisena, S M Musser, J A Kelley, C F Perno and D G Johns
      Drug Metabolism and Disposition July 1993, 21 (4) 738-744;

  17. Suzuki, A

    1. Pharmacokinetics of zenarestat, an aldose reductase inhibitor, in male and female diabetic rats.
      Y Tanaka, T Sawamoto, A Suzuki and T Kimura
      Drug Metabolism and Disposition July 1993, 21 (4) 677-681;

  18. Swinney, D C

    1. Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A.
      T Prueksaritanont, M A Correia, A E Rettie, D C Swinney, P E Thomas and L Z Benet
      Drug Metabolism and Disposition July 1993, 21 (4) 730-737;

T

  1. Tanaka, Y

    1. Pharmacokinetics of zenarestat, an aldose reductase inhibitor, in male and female diabetic rats.
      Y Tanaka, T Sawamoto, A Suzuki and T Kimura
      Drug Metabolism and Disposition July 1993, 21 (4) 677-681;

  2. Tani, M

    1. The kinetic characterization of S-mephenytoin 4-hydroxylase (P-450IICMP) activity in human liver samples obtained as surgical waste from Japanese patients.
      K Chiba, K Kobayashi, M Tani, K Manabe and T Ishizaki
      Drug Metabolism and Disposition July 1993, 21 (4) 747-749;

  3. Tenney, K A

    1. Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment.
      N L Ferguson, B S Donahue, K A Tenney and E T Morgan
      Drug Metabolism and Disposition July 1993, 21 (4) 745-746;

  4. Thomas, P E

    1. Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A.
      T Prueksaritanont, M A Correia, A E Rettie, D C Swinney, P E Thomas and L Z Benet
      Drug Metabolism and Disposition July 1993, 21 (4) 730-737;

V

  1. Van Breemen, R B

    1. Application of an immobilized digestive enzyme assay to measure chemical and enzymatic hydrolysis of the cyclic peptide antibiotic lysobactin.
      R K Blackburn and R B Van Breemen
      Drug Metabolism and Disposition July 1993, 21 (4) 573-579;

  2. Varga, S L

    1. Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.
      S K Balani, M E Goldman, L R Kauffman, S L Varga, J A O'Brien, S J Smith, T V Olah, H G Ramjit, T W Schorn and S M Pitzenberger
      Drug Metabolism and Disposition July 1993, 21 (4) 598-604;

  3. Venkataraman, P S

    1. Redox cycling and hepatotoxicity of diquat in aging male Fischer 344 rats.
      L E Rikans, Y Cai, S D Kosanke and P S Venkataraman
      Drug Metabolism and Disposition July 1993, 21 (4) 605-610;

  4. Veyre, A

    1. Biodistribution and metabolism of orally administered mitozolomide in mice.
      F Gachon, P Labarre, D Godeneche, M F Moreau, J Papon, J C Madelmont, A Veyre and G Gaillard
      Drug Metabolism and Disposition July 1993, 21 (4) 560-566;

W

  1. Wang, L

    1. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS).
      M Nadai, T Hasegawa, K Kato, L Wang, T Nabeshima and N Kato
      Drug Metabolism and Disposition July 1993, 21 (4) 611-616;

  2. Washington, C B

    1. Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;

  3. White, W R

    1. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
      C E Cook, A R Jeffcoat, J M Hill, D E Pugh, P K Patetta, B M Sadler, W R White and M Perez-Reyes
      Drug Metabolism and Disposition July 1993, 21 (4) 717-723;

  4. Wichmann, J K

    1. Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;

  5. Wong, K K

    1. Isolation and identification of 3-carbamoyloxy-2-phenylpropionic acid as a major human urinary metabolite of felbamate.
      V E Adusumalli, Y M Choi, L A Romanyshyn, R E Sparadoski, J K Wichmann, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition July 1993, 21 (4) 710-716;

Y

  1. Yang, Z C

    1. Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
      J R Cashman, S B Park, Z C Yang, C B Washington, D Y Gomez, K M Giacomini and C M Brett
      Drug Metabolism and Disposition July 1993, 21 (4) 587-597;

Z

  1. Zimmerman, C L

    1. Disposition of (-)carbovir in the in situ perfused rat liver and intestinal vasculature preparations.
      I Soria and C L Zimmerman
      Drug Metabolism and Disposition July 1993, 21 (4) 724-729;
Back to top

In this issue

Advertisement